Objective
"In our ERC grant GEnetic NEtworks as a tool for anti-CAncer Drug Development we used phenotypic screening and genetic networks to identify the DNA repair protein MTH1 as a critical component for cancer cell survival and we developed selective sub nM inhibitors to MTH1, which specifically kill cancer cells and tumours, whilst being less toxic to primary cells. Our approach provides a novel concept for treating cancer. Here, we want to explore the commercial potential of the MTH1 inhibitors identified in the ERC grant."
Fields of science
Call for proposal
ERC-2013-PoC
See other projects for this call
Funding Scheme
CSA-SA(POC) - Supporting action (Proof of Concept)
Host institution
KAROLINSKA INSTITUTET
Address
Nobels Vag 5
17177 Stockholm
Sweden
17177 Stockholm
Sweden
See on map
Activity type
Higher or Secondary Education Establishments
Administrative Contact
Jill Blomstrand (Mrs.)
EU contribution
€ 105 990
Beneficiaries (2)
KAROLINSKA INSTITUTET
Sweden
EU contribution
€ 105 990
Address
Nobels Vag 5
17177 Stockholm
17177 Stockholm
See on map
Activity type
Higher or Secondary Education Establishments
Administrative Contact
Jill Blomstrand (Mrs.)
KAROLINSKA INSTITUTET INNOVATIONS AB
Sweden
EU contribution
€ 44 010
Address
Nanna Svartz Vag 6a
171 65 Solna
171 65 Solna
See on map
Activity type
Private for-profit entities (excluding Higher or Secondary Education Establishments)
Administrative Contact
Christian Krog-Jensen (Dr.)